Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
93.8M
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
33.6M
-
Shares change
-
+757K
-
Total reported value, excl. options
-
$708M
-
Value change
-
+$17.1M
-
Number of buys
-
47
-
Number of sells
-
-26
-
Price
-
$21.05
Significant Holders of Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") (CRNX) as of Q3 2021
97 filings reported holding CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") as of Q3 2021.
Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") (CRNX) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.6M shares
of 93.8M outstanding shares and own 35.86% of the company stock.
Largest 10 shareholders include FMR LLC (4.43M shares), PERCEPTIVE ADVISORS LLC (3.96M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (3M shares), ORBIMED ADVISORS LLC (3M shares), BlackRock Inc. (2.62M shares), Bain Capital Life Sciences Investors, LLC (1.68M shares), VANGUARD GROUP INC (1.68M shares), 5AM Venture Management, LLC (1.36M shares), STATE STREET CORP (1.12M shares), and BVF INC/IL (954K shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.